NewAmsterdam Pharma Co. NV (NAMS)
35.58
+0.95
(+2.74%)
USD |
NASDAQ |
Feb 20, 16:00
35.51
-0.07
(-0.20%)
Pre-Market: 20:00
NewAmsterdam Pharma EPS Diluted (Quarterly) : -0.6549 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -1.376 |
| ProQR Therapeutics NV | -0.1221 |
| argenx SE | -- |
| Pharming Group NV | 0.109 |
| Pharvaris NV | -0.6971 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.92M |
| Revenue (Quarterly) | 0.032M |
| Total Expenses (Quarterly) | 74.96M |
| Enterprise Value | 3.397B |
| Gross Profit Margin (Quarterly) | -84.38% |
| Profit Margin (Quarterly) | -234.1K% |
| Earnings Yield | -4.91% |
| Normalized Earnings Yield | -4.596 |